Curated News
By: NewsRamp Editorial Staff
March 28, 2024
NeuroOne's Innovative Electrode Brain Monitoring Revolutionizes Neurological Disorders
Discuss on Reddit
Discuss on SubstackTLDR
- NeuroOne Medical Technologies Corp. aims to provide better outcomes for patients with neurological disorders through its high-definition, minimally invasive thin film electrodes, potentially gaining a competitive advantage in the market.
- NeuroOne's Evo® Cortical Electrode and Evo® sEEG Electrode portfolio, made with polyimide thin film, reduce trauma to the brain and enable recording and monitoring of brain activity for less than 30 days, revolutionizing the way brain diseases are diagnosed and treated.
- NeuroOne's innovative electrodes have the potential to improve the quality of life and mortality rates of epilepsy patients, making tomorrow better than today by offering more accurate diagnoses and potential treatment options.
- NeuroOne's technology may lead to improved outcomes for patients with neurological disorders, offering a game-changing approach to diagnosing and potentially treating epilepsy, while also revolutionizing the landscape of neurological disorders.
Impact - Why it Matters
Millions of people worldwide suffer from epilepsy, and current treatments fall short for many patients, resulting in uncontrolled seizures and significant impact on quality of life. NeuroOne's groundbreaking technology provides new options for surgical placement, potentially smaller incisions, and enhanced signal quality, ultimately leading to more confident diagnoses and improved outcomes for patients. This innovation has the potential to revolutionize the landscape of neurological disorders, offering hope and relief to millions of sufferers around the world.
Summary
NeuroOne Medical Technologies Corp. is revolutionizing the landscape of neurological disorders with its innovative high-definition, minimally invasive thin film electrodes used for intracranial monitoring. The company's Evo® Cortical Electrode and Evo® sEEG Electrode technologies enable doctors to record and monitor brain activity for less than 30 days, providing new options for surgical placement and potentially smaller incisions. The company's recent FDA 510(k) clearance for its OneRF™ Ablation System has the potential to revolutionize diagnoses and treatment of brain diseases, including epilepsy.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, NeuroOne's Innovative Electrode Brain Monitoring Revolutionizes Neurological Disorders
